4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000245
EVP Research sold 27,114 shares at an average $66.16 ($1,793,744)
- EVP Research acquired 27,114 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Swayze Eric · EVP Research
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +14,142 | $53.77 | $760,415 | 51,444 | D |
| 2025-10-01 | Sale : show line 2 in the form 10b5-1 | −14,142 | $66.09 | $934,662 | 37,302 | D |
| 2025-10-02 | Exercise or conversion : show line 3 in the form 10b5-1 | +12,972 | $53.77 | $697,504 | 50,274 | D |
| 2025-10-02 | Sale : show line 4 in the form 10b5-1 | −12,972 | $66.23 | $859,082 | 37,302 | D |
| Open-market sales · 27,114 sh · avg $66.16 · $1,793,744 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-10-01 | Exercise or conversion : show line 5 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −14,142 | 12,972 | D |
| 2025-10-02 | Exercise or conversion : show line 6 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −12,972 | 0 | D |
Loading xslF345X05/edgardoc.xml…